title: Effects of rivaroxaban on coagulation tests in patients with non-valvular atrial fibrillation under real-life conditions.
authors.affiliation: Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil.
authors.forename: V M
authors.initials: VM
authors.lastname: Silva
authors.affiliation: Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil.
authors.forename: M
authors.initials: M
authors.lastname: Scanavacca
authors.affiliation: Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil.
authors.forename: F
authors.initials: F
authors.lastname: Darrieux
authors.affiliation: Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil.
authors.forename: C
authors.initials: C
authors.lastname: Cavalheiro-Filho
authors.affiliation: Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil. Electronic address: labcelia@incor.usp.br.
authors.forename: C C
authors.initials: CC
authors.lastname: Strunz
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000069552:Rivaroxaban / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D000069552:Rivaroxaban
keywords: Activated partial thromboplastin time; Anti-Xa assay; Prothrombin time; Rivaroxaban